Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geriatric Depression: Neurobiology of Treatment
NCT00178035Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of paroxetine in major depressive disorder (MDD) (3 arms), sponsored by University of Pittsburgh. Primary endpoint: Rapid resolution of depressive symptoms. Started Dec 1999; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00178035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178035.